Marel: Ársuppgjör 2020 birt 3. febrúar, rafrænn afkomufundur 4. febrúar 2021
20 janv. 2021 13h39 HE
|
Marel hf.
Marel hf. mun birta ársuppgjör 2020 eftir lokun markaða þann 3. febrúar 2021. Rafrænn afkomufundur með markaðsaðilum Fimmtudaginn 4. febrúar 2021 kl. 8:30 verður haldinn afkomufundur fyrir...
Marel: 2020 results published on 3 February, virtual investor meeting on 4 February 2021
20 janv. 2021 13h39 HE
|
Marel hf.
Marel hf. will publish its 2020 consolidated financial statements after market closing on 3 February 2021. Earnings conference call and webcast On Thursday 4 February 2021, at 8:30 am GMT (9:30 am...
Gran Colombia Reports Fourth Quarter and Full Year 2020 Gold Production; Meets Annual Guidance for Fifth Consecutive Year
13 janv. 2021 07h00 HE
|
Gran Colombia Gold
TORONTO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that it produced a total of 19,958 ounces of gold in December 2020 bringing the total for...
Amryt Pharma Plc - Full Year 2019 RESULTS
11 mai 2020 07h00 HE
|
Amryt Pharma Plc
May 11, 2020 AIM: AMYT Euronext Growth: AYP AMRYT PHARMA PLC (“Amryt” or the “Company”) FY 2019 RESULTS Transformational year of performance and growth for AmrytAegerion integration...
Horizon Discovery Group plc Full Year Unaudited Results for the Twelve Months Ended 31 December 2019
27 avr. 2020 07h00 HE
|
Horizon Discovery Group plc
Horizon Discovery Group plcFull Year Unaudited Results for the Twelve Months Ended 31 December 2019 Cambridge, UK, 27 April 2020: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group"...
Silence Therapeutics Final results for the year ended 31 December 2019
14 avr. 2020 07h00 HE
|
Silence Therapeutics
Final results for the year ended 31 December 2019 April 14, 2020 LONDON, Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of...
Surna Reports Q4 2019 and Full Year Results
24 mars 2020 07h10 HE
|
Surna Inc
Announces $15.2 Million in 2019 Revenue and Downsizing of Operations in Response to Coronavirus Boulder, Colorado, March 24, 2020 (GLOBE NEWSWIRE) -- Surna Inc. (OTCQB: SRNA) announced today...
Innate Pharma présente ses résultats financiers et l’avancée de son portefeuille pour l’année 2019
10 mars 2020 02h00 HE
|
INNATE PHARMA
INNATE PHARMA PRÉSENTE SES RÉSULTATS FINANCIERS ET L’AVANCÉE DE SON PORTEFEUILLE POUR L’ANNÉE 2019 Innate étend sa présence sur les marchés financiers à travers une offre globale, comprenant une...
Innate Pharma reports full year 2019 financial results and business update
10 mars 2020 02h00 HE
|
INNATE PHARMA
INNATE PHARMA REPORTS FULL YEAR 2019 FINANCIAL RESULTS AND BUSINESS UPDATE Innate globally expands its capital markets presence with a successful NASDAQ IPO and Global Offering that provided gross...
Innate Pharma Reports Full Year 2019 Financial Results and Business Update
10 mars 2020 02h00 HE
|
INNATE PHARMA
Innate globally expands its capital markets presence with a successful NASDAQ IPO and Global Offering that provided gross proceeds of $79.1 million (€71.5 million1)Monalizumab to advance to a Phase...